Response Biomedical Closes on $7.7M Private Placement | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) –Response Biomedical said on Wednesday that it has closed on a previously announced C$8 million ($7.7 million) private placement.

More than 13.3 million shares in aggregate were placed to Caduceus Private Investments III, OrbiMed Associates III, and Caduceus Asia Partners, all affiliates of OrbiMed Advisors. Each share was priced at C$0.60.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.